Verma Anita, Ngundi Miriam M, Meade Bruce D, De Pascalis Roberto, Elkins Karen L, Burns Drusilla L
Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Clin Vaccine Immunol. 2009 Oct;16(10):1405-12. doi: 10.1128/CVI.00194-09. Epub 2009 Aug 5.
Anthrax toxin neutralization assays are used to measure functional antibody levels elicited by anthrax vaccines in both preclinical and clinical studies. In this study, we investigated the magnitude and molecular nature of Fc gamma (Fcgamma) receptor-dependent toxin neutralization observed in commonly used forms of the anthrax toxin neutralization assay. Significantly more Fcgamma receptor-dependent neutralization was observed in the J774A.1 cell-based assay than in the RAW 264.7 cell-based assay, a finding that could be due to the larger numbers of Fcgamma receptors that we found on J774A.1 cells by using flow cytometry. Thus, the extent to which Fcgamma receptor-dependent neutralization contributes to the total neutralization measured by the assay depends on the specific cell type utilized in the assay. Using Fcgamma receptor blocking monoclonal antibodies, we found that at least three murine Fcgamma receptor classes, IIB, III, and IV, can contribute to Fcgamma receptor-dependent neutralization. When antibodies elicited by immunization of rabbits with protective-antigen-based anthrax vaccines were analyzed, we found that the magnitude of Fcgamma receptor-dependent neutralization observed in the J774A.1 cell-based assay was dependent on the concentration of protective antigen utilized in the assay. Our results suggest that the characteristics of the antibodies analyzed in the assay (e.g., species of origin, isotype, and subclass), as well as the assay design (e.g., cell type and protective antigen concentration), could significantly influence the extent to which Fcgamma receptor-dependent neutralization contributes to the total neutralization measured by anthrax toxin neutralization assays. These findings should be considered when interpreting anthrax toxin neutralization assay output.
炭疽毒素中和试验用于在临床前和临床研究中测量炭疽疫苗引发的功能性抗体水平。在本研究中,我们调查了在常用形式的炭疽毒素中和试验中观察到的Fcγ(Fcgamma)受体依赖性毒素中和的程度和分子性质。在基于J774A.1细胞的试验中观察到的Fcgamma受体依赖性中和明显多于基于RAW 264.7细胞的试验,这一发现可能是由于我们通过流式细胞术在J774A.1细胞上发现了更多数量的Fcgamma受体。因此,Fcgamma受体依赖性中和对试验测量的总中和作用的贡献程度取决于试验中使用的特定细胞类型。使用Fcgamma受体阻断单克隆抗体,我们发现至少三种小鼠Fcgamma受体类别,即IIB、III和IV,可以促成Fcgamma受体依赖性中和。当分析用基于保护性抗原的炭疽疫苗免疫兔子产生的抗体时,我们发现在基于J774A.1细胞的试验中观察到的Fcgamma受体依赖性中和程度取决于试验中使用的保护性抗原浓度。我们的结果表明,试验中分析的抗体特征(例如,来源物种、同种型和亚类)以及试验设计(例如,细胞类型和保护性抗原浓度)可能会显著影响Fcgamma受体依赖性中和对炭疽毒素中和试验测量的总中和作用的贡献程度。在解释炭疽毒素中和试验结果时应考虑这些发现。